What Happened?
New York, NY-based Rgenix Appointed David Darst as Chief operating officer
About the Company
Rgenix is a preclinical stage pharmaceutical company with a mission to develop the world`s first cancer therapies designed specifically to target cancer metastasis, the main cause of mortality in cancer patients. Rgenix is leading the revolution in next-generation cancer therapies with first-in-class lead drug candidates for several aggressive cancer subtypes, including Triple-Negative Breast Cancer, Melanoma and Colorectal Cancer.
About the Person
David Darst is Chief operating officer at Rgenix. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile